
Hybrid Neuroendocrine Cancers: Pathology, Grade Transformation, and Emerging Therapies
NETCast
00:00
Therapy-Driven De-differentiation and PRRT
Shagufta Shaheen describes selective pressure from therapies like PRRT and the need to re-biopsy and restage.
Play episode from 11:01
Transcript


